An exchange-traded fund that tracks the NYSE Arca Biotechnology Index, providing exposure to a basket of U.S.-listed biotechnology companies. The fund uses an equal-weighted approach, giving similar allocation to large and mid‑cap biotech firms engaged in drug development and life sciences research....
2 members of Congress have disclosed 2 trades in First Trust NYSE Arca Biotechnology Index Fund (FBT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-02-06 | FRED UPTON | sell | $250K – $500K |
| 2014-05-22 | JAMES B. RENACCI | buy | $1K – $15K |